SBC Medical Group (SBC) to Announce Quarterly Earnings on Thursday

SBC Medical Group (NASDAQ:SBC) is projected to release its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect SBC Medical Group to post earnings of $0.12 per share and revenue of $45.3710 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last posted its earnings results on Thursday, May 14th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. The firm had revenue of $43.06 million during the quarter, compared to analyst estimates of $41.66 million. SBC Medical Group had a net margin of 24.09% and a return on equity of 15.90%. On average, analysts expect SBC Medical Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

SBC Medical Group Stock Performance

Shares of SBC stock opened at $3.08 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.82 and a quick ratio of 3.78. The firm has a 50-day moving average of $3.06 and a 200-day moving average of $3.59. SBC Medical Group has a one year low of $2.78 and a one year high of $5.07. The company has a market cap of $315.95 million, a P/E ratio of 7.90 and a beta of 0.59.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on SBC shares. Wall Street Zen raised shares of SBC Medical Group to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings cut shares of SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, SBC Medical Group has a consensus rating of “Hold” and a consensus target price of $8.50.

Institutional Investors Weigh In On SBC Medical Group

Hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC purchased a new stake in SBC Medical Group during the second quarter worth about $455,000. Millennium Management LLC purchased a new position in SBC Medical Group in the third quarter valued at about $219,000. New York State Common Retirement Fund purchased a new position in SBC Medical Group in the second quarter valued at about $104,000. XTX Topco Ltd bought a new position in shares of SBC Medical Group during the 2nd quarter valued at approximately $64,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of SBC Medical Group by 91.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,341 shares of the company’s stock valued at $118,000 after acquiring an additional 13,074 shares during the period. 60.82% of the stock is currently owned by institutional investors.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.